Keros Therapeutics, Inc. (KROS) vs Niagen Bioscience, Inc. (NAGE)

Keros Therapeutics, Inc. and Niagen Bioscience, Inc. are both Biotechnology companies. Keros Therapeutics, Inc. and Niagen Bioscience, Inc. are of similar size ($238.2M and $229.0M). Keros Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Niagen Bioscience, Inc. trades at 15.2×. Niagen Bioscience, Inc. grew revenue faster over the last twelve months: 11.0% against −84.6%. Niagen Bioscience, Inc. has the higher net margin (12.4% vs 0.00%) and the higher return on invested capital (42.0% vs −1,345.3%). Across the 18 metrics below, Niagen Bioscience, Inc. leads on 10 and Keros Therapeutics, Inc. on 8.